Category Archive: Pharmaceutical Litigation

Prescription drugs are meant to help patients recover from or cope with encumbering medical conditions. Unfortunately, not all prescription drugs are made or distributed with patients’ best interests in mind; many cause undue harm, injury, and even death. If you are the victim of a pharmaceutical drug that’s caused you harm that you would not have suffered but for the medication, you have the right to pursue a civil action. At Napoli Shkolnik, PLLC our attorneys can help you to determine who is liable for your injuries, and file a claim to recover damages for economic and noneconomic losses.

Jennifer Liakos Named to Abilify Steering Committee

Jennifer Liakos Named to Abilify Steering Committee

| Pharmaceutical Litigation
Congratulations Napoli Shkolnik partner Jennifer R. Liakos for being appointed on the Plaintiffs’ Steering Committee in the In re Abilify (Aripiprazole)) Products Liability Litigation (Case No. 3:16-md02734) by Chief United States District Judge M. Casey Rodgers. The Order states there were many applications for this multi-district litigation (MDL); however, the Court appointed the MDL leadership…Read the article
Napoli Shkolnik Featured for Bristol Myers Litigation

Napoli Shkolnik Featured for Bristol Myers Litigation

| Pharmaceutical Litigation
As was reported by Tony Mauro of the NYLJ and Ben Hancock of The Recorder, personal jurisdiction cases are a hot issue right now, with four cases pending before the U.S. Supreme Court. In the Bristol-Myers case, the California Supreme Court ruled that both in-state and out-of-state plaintiffs could sue the pharmaceutical company in California…Read the article
NYLJ: J&J Knew Cancer Risks with Talc Products

NYLJ: J&J Knew Cancer Risks with Talc Products

| Pharmaceutical Litigation
Johnson & Johnson has known about the increased ovarian cancer risk associated with the use of their talc-based products but failed to warn women who used it. In fact, the supposed family friendly company did nothing, not even putting a warning label on the box despite the numerous research studies showing the connection between talcum…Read the article
Napoli Shkolnik Noted For Top Product Liability Case

Napoli Shkolnik Noted For Top Product Liability Case

| Pharmaceutical Litigation
Law360 Publishes Year-End Report: Recognizes Napoli Shkolnik PLLC Litigation As One of the Top Product Liability Cases of 2016 Law360 Reviews the most significant product liability ruling of the past year. Law360 has assembled a list of the top Product Liability Cases of 2016 in their Year-End Report and has named Bristol-Myers Squibb Co. v.…Read the article
Medtronic Recalls Neurovascular Products

Medtronic Recalls Neurovascular Products

| Pharmaceutical Litigation
Manufacturer Medtronic plc has recalled (officially October 5, 2016) several of its products due to potential separation and detachment of the Polytetrafluoroethylene (PTFE) coating. The PTFE coating is meant to reduce the friction and ease the navigation between the devices but if it separates from the device it could enter the blood stream of the patient.…Read the article
Hunter Shkolnik Quoted in ALM/Texas Lawyer About Chemo Drug

Hunter Shkolnik Quoted in ALM/Texas Lawyer About Chemo Drug

| Pharmaceutical Litigation
UPDATE: Hunter Shkolnik has been appointed to the Taxotere Products Liability Litigation Plaintiffs’ Steering Committee by United States District Judge, Kurt D. Engelhardt Partner Hunter Shkolnik submitted an application for lead counsel appointment consideration in the Taxotere chemotherapy drug liability multi-district litigation. There has been an unusually large number of plaintiff attorney submissions with more…Read the article
Court Says Out-of-State Victims May Sue in California

Court Says Out-of-State Victims May Sue in California

| Pharmaceutical Litigation
California’s highest court upheld the rule of law that out-of-state victims can join California residents in suing a pharmaceutical company in California State Court where the claims and injuries are similar. This decision held that Bristol Myers Squibb, already being sued by hundreds of California residents for its marketing of the popular drug Plavix, is…Read the article
Jennifer Liakos Featured in Northern CA Newspaper

Jennifer Liakos Featured in Northern CA Newspaper

| Pharmaceutical Litigation
Ms. Liakos, who recently named as a member of the Plaintiffs’ Executive Steering Committee in Viagra Products Liability Litigation (MDL 2), also said that “the best results would include fair and adequate compensation for those injured by the drug, but would also include Pfizer educating physicians and consumers about the risks associated with this drug. If…Read the article
Drug Safety Communication Alert

Drug Safety Communication Alert

| Pharmaceutical Litigation
Napoli Shkolnik PLLC has learned that the Federal Drug Administration (FDA) has issued an alert for the patients of diabetes drugs Invokana and Invokamet. As part of ongoing clinical trials, the interim safety results have found an increase in leg and foot amputations, mostly affecting the toes, in patients being treated with the diabetes medication…Read the article
FDA Finds Adverse Reactions to Meds at Profound Level

FDA Finds Adverse Reactions to Meds at Profound Level

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) has found that there were an astounding 123,000 deaths caused by prescribed medications in 2014, as well as 800,000 serious health complications that caused hospitalization and/or permanent disability. These adverse effects of prescription drugs, according to the FDA, have tripled in the last decade. Keep in mind that…Read the article